240 related articles for article (PubMed ID: 11748475)
1. Elevated IL-8 levels in the drainage vein of resectable Dukes' C colorectal cancer indicate high risk for developing hepatic metastasis.
Haraguchi M; Komuta K; Akashi A; Matsuzaki S; Furui J; Kanematsu T
Oncol Rep; 2002; 9(1):159-65. PubMed ID: 11748475
[TBL] [Abstract][Full Text] [Related]
2. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.
Minagawa N; Nakayama Y; Hirata K; Onitsuka K; Inoue Y; Nagata N; Itoh H
Anticancer Res; 2002; 22(5):2957-63. PubMed ID: 12530025
[TBL] [Abstract][Full Text] [Related]
3. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer.
Kumar H; Heer K; Lee PW; Duthie GS; MacDonald AW; Greenman J; Kerin MJ; Monson JR
Clin Cancer Res; 1998 May; 4(5):1279-85. PubMed ID: 9607588
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
[TBL] [Abstract][Full Text] [Related]
6. Circulating vascular endothelial growth factor in patients with colorectal cancer.
Fujisaki K; Mitsuyama K; Toyonaga A; Matsuo K; Tanikawa K
Am J Gastroenterol; 1998 Feb; 93(2):249-52. PubMed ID: 9468253
[TBL] [Abstract][Full Text] [Related]
7. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer.
Nakayama Y; Sako T; Shibao K; Onitsuka K; Nagashima N; Hirata K; Nagata N; Itoh H
Anticancer Res; 2000; 20(6A):4097-102. PubMed ID: 11131678
[TBL] [Abstract][Full Text] [Related]
8. [A study on correlation of hepatic metastasis of colorectal cancer to vascular endothelial growth factor, angiopoietin-2, and fibronectin].
Liang XY; Wang T; Yang XD; Qiu YJ; Zhu LW; Wang PZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jan; 8(1):20-3. PubMed ID: 16148991
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T
Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629
[TBL] [Abstract][Full Text] [Related]
10. [Significance of p53 and VEGF expression in liver metastasis from colorectal cancer].
Yamamura T; Matsuzaki H; Ozasa T; Matsuoka H; Tanaka K; Oikawa H; Akaishi O; Tsukikawa S; Yamaguchi S
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1355-7. PubMed ID: 9703827
[TBL] [Abstract][Full Text] [Related]
11. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver mestastasis vascularity and volume.
Davies MM; Jonas SK; Kaur S; Allen-Mersh TG
Br J Cancer; 2000 Mar; 82(5):1004-8. PubMed ID: 10737380
[TBL] [Abstract][Full Text] [Related]
12. Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer.
Verbeke H; De Hertogh G; Li S; Vandercappellen J; Noppen S; Schutyser E; El-Asrar AA; Opdenakker G; Van Damme J; Geboes K; Struyf S
Hum Pathol; 2010 Jul; 41(7):990-1001. PubMed ID: 20334899
[TBL] [Abstract][Full Text] [Related]
13. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.
Ng IO; Poon RT; Lee JM; Fan ST; Ng M; Tso WK
Am J Clin Pathol; 2001 Dec; 116(6):838-45. PubMed ID: 11764072
[TBL] [Abstract][Full Text] [Related]
14. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
15. Comparison of angiogenic factor levels in tumor drainage and peripheral venous blood from colorectal cancer patients.
Tien YW; Chang KJ; Chiu YF; Huang KW; Lee PH
Ann Surg Oncol; 2006 Nov; 13(11):1357-63. PubMed ID: 17001510
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma].
Fan YZ; Li GM; Huang GP; Li XP
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):477-82. PubMed ID: 17143789
[TBL] [Abstract][Full Text] [Related]
18. Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production.
O'Hara RJ; Greenman J; MacDonald AW; Gaskell KM; Topping KP; Duthie GS; Kerin MJ; Lee PW; Monson JR
Clin Cancer Res; 1998 Aug; 4(8):1943-8. PubMed ID: 9717823
[TBL] [Abstract][Full Text] [Related]
19. [An angiogenesis study of Dukes' B colonic tumors].
Pantalone D; Ziche M; Messerini L; Pazzagli M; Morbidelli L; Parenti A; Donnini S; Palomba AR; Tricarico C; Paolucci R; Taruffi F; Andreoli F
Clin Ter; 1999; 150(5):331-7. PubMed ID: 10687262
[TBL] [Abstract][Full Text] [Related]
20. The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer.
Lantzsch T; Hefler L; Krause U; Kehl A; Goepel C; Koelbl H; Dunst J; Lampe D
Anticancer Res; 2002; 22(3):1925-8. PubMed ID: 12168895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
